Whooping Cough Treatment
Azithromycin is the first-line treatment for pertussis across all age groups, with a 5-day course (10 mg/kg on day 1, then 5 mg/kg daily on days 2-5 for children; 500 mg on day 1, then 250 mg daily on days 2-5 for adults) being as effective as 14 days of erythromycin while causing significantly fewer gastrointestinal side effects and improving compliance. 1, 2
First-Line Antibiotic Therapy
Azithromycin Dosing by Age
- Infants <1 month: 10 mg/kg per day for 5 days (preferred over erythromycin due to lower risk of infantile hypertrophic pyloric stenosis) 1
- Infants 1-5 months: 10 mg/kg per day for 5 days 1
- Children ≥6 months: 10 mg/kg (maximum 500 mg) on day 1, followed by 5 mg/kg per day (maximum 250 mg) on days 2-5 1
- Adults: 500 mg on day 1, followed by 250 mg per day on days 2-5 1
Alternative Macrolides
- Clarithromycin is equally effective as azithromycin and can be used as first-line therapy, particularly in infants 1-5 months of age 1
- Dosing: 15 mg/kg per day divided into two doses for 7 days in children; 500 mg twice daily for 7 days in adults 3
Second-Line Option
- Trimethoprim-sulfamethoxazole (TMP-SMZ) for patients >2 months with macrolide contraindications (hypersensitivity to any macrolide agent) 1, 4
Timing of Treatment: Critical for Effectiveness
Start antibiotics immediately upon clinical suspicion—do not wait for culture confirmation. 5
- Early treatment (catarrhal phase, first 2 weeks): Rapidly clears B. pertussis from the nasopharynx, decreases coughing paroxysms, and reduces complications 5
- Late treatment (paroxysmal phase, >3 weeks): Limited clinical benefit but still indicated to prevent transmission 5
- Approximately 80-90% of untreated patients spontaneously clear bacteria within 3-4 weeks from cough onset 1
Isolation Requirements
- Isolate patients at home and away from work/school for 5 days after starting antibiotics 5
- Without treatment, patients remain infectious for approximately 3 weeks after cough onset 3
Post-Exposure Prophylaxis
Use the same antibiotic regimens and dosing as for treatment. 1, 3
Who Should Receive Prophylaxis
- All household contacts regardless of age or vaccination status 3
- High-priority contacts: Infants <12 months (especially <4 months), pregnant women in third trimester 1, 3
- Administer within 21 days of exposure for effectiveness 3
Rationale
- Pertussis has a secondary attack rate exceeding 80% among susceptible household contacts 3
- Prophylaxis aims to eradicate B. pertussis from the nasopharynx of infected persons (symptomatic or asymptomatic) and create a protective "cocoon" around vulnerable infants 6, 3
Evidence Supporting Azithromycin Superiority
- A large multicenter randomized trial demonstrated 100% bacterial eradication with both azithromycin (5 days) and erythromycin (14 days), but azithromycin caused significantly fewer gastrointestinal adverse events (18.8% vs 41.2%) 2
- Compliance was markedly superior with azithromycin: 90% of children took 100% of prescribed doses versus only 55% with erythromycin 2
- Cochrane systematic review confirmed short-term antibiotics (azithromycin 3 days, clarithromycin 7 days) were equally effective as 14-day erythromycin with fewer side effects (RR 0.66; 95% CI 0.52-0.83) 7
Important Medication Considerations
Azithromycin Precautions
- Do not administer simultaneously with aluminum- or magnesium-containing antacids (reduces absorption) 1
- Use with caution in patients with impaired hepatic function 1
- Monitor for drug interactions with agents metabolized by cytochrome P450 (digoxin, triazolam, ergot alkaloids) 1
Erythromycin Warnings
- Associated with infantile hypertrophic pyloric stenosis (IHPS) in infants <1 month—avoid if possible 1, 6
- If erythromycin must be used: 40-50 mg/kg/day in children, 1-2 g per day in adults for 14 days 5, 4
- Erythromycin resistance is rare (<1%) 5
Therapies That Do NOT Work
- Long-acting β-agonists, antihistamines, corticosteroids, and pertussis immunoglobulin have no significant benefit in controlling coughing paroxysms 5
Common Pitfalls to Avoid
- Delaying treatment while awaiting culture results: Start antibiotics immediately based on clinical suspicion (cough >2 weeks with paroxysms, post-tussive vomiting, or inspiratory whoop) 5
- Failing to provide prophylaxis to household contacts: This is critical to prevent severe disease in vulnerable infants 3
- Using erythromycin in young infants: Azithromycin is safer due to lower IHPS risk 1, 6
- Expecting antibiotics to stop established paroxysms: Antibiotics eliminate bacteria and prevent transmission but do not alter the clinical course once paroxysmal coughing is established 7, 2